诺华制药首款婴幼儿疟疾药物在瑞士获批

Core Insights - Novartis has received approval in Switzerland for its first drug aimed at treating malaria in infants, named Coartem Baby [1] - The drug is expected to gain rapid approval in eight African countries involved in the evaluation process, where it is also known as Riamet Baby [1]